Search Results 741-750 of 17565 for Assay
NOTE: Bone marrow aspirate specimen must be submitted to Adaptive Biotechnologies for clonoSEQ Assay. NOTE: Adaptive Biotechnologies will release results to ...
Serum free light chain (FLC) assay: Involved FLC level ≥10 mg/dL (≥100 mg/L) and an abnormal serum FLC ratio (<0.26 or >1.65) 5. Resolved acute effects of ...
explorative studies. 4. The IDH mutation, and other applicable gene/molecular alterations (see Table 10-2) are determined by a validated assay as performed in ...
... assays: DAKO 22C3, DAKO 28-8, or SP263. Note ... The report must indicate the result as well as the CLIA number of the laboratory that performed the assay.
Classification of BRCA2 variants of uncertain significance (VUS) using an ACMG/AMP model incorporating a homology-directed repair (HDR) functional assay.
Patients must have a potential germline mutation, as determined by the NCI-MATCH tumor profiling assay; Patients must be able to speak English and hear by ...
The purpose of this study is to evaluate the Renasight™ test, a next generation sequencing (NGS) gene mutation assay, for patients with chronic kidney ...
Mayo Clinic investigators have developed a 3D microcancer assay, growing microtumors from patient tissue. By studying drug responses to these microtumors ...
... assays using patient peripheral blood immune cells or serum. Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal ...
Creatinine will be measured by enzymatic assay with calibration traceable to the international standard reference materials and minimal bias compared to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.